Tango Therapeutics, Inc.
USD21.50
-1.60 (-6.93%)
CEO
Malte Peters
IPO Date
2020-09-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.66
Prev. Close
$23.10
Day Low
$21.36
Day High
$23.05
52W Low
$2.45
52W High
$28.41
Market Cap
$2.50B
Volume
2.96M
| 25,900 |
| $21.19 |
| 5 May 2026 | Crystal Adam | President, R&D | S-Sale | Disposed | 1,100 | $22.00 |
| 5 May 2026 | Crystal Adam | President, R&D | M-Exempt | Disposed | 27,000 | $5.20 |
| 5 May 2026 | Gall Matthew | Chief Financial Officer | A-Award | Acquired | 40,000 | $0.00 |
| 5 May 2026 | Gall Matthew | Chief Financial Officer | A-Award | Acquired | 240,000 | $20.98 |
| 1 May 2026 | Lee Sung | director | A-Award | Acquired | 12,300 | $0.00 |
| 1 May 2026 | Lee Sung | director | A-Award | Acquired | 5,200 | $22.06 |
| 24 Apr 2026 | Newcomb Jessica | Principal Accounting Officer | Disposed | 0 | $0.00 |
| 24 Apr 2026 | Newcomb Jessica | Principal Accounting Officer | Disposed | 130,000 | $4.26 |